Evidence map›Paper›PMID 35608736›Full record

Observational studyNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2022

Autonomic dysfunction in non-critically ill COVID-19 patients during the acute phase of disease: an observational, cross-sectional study.

Irene Scala, Simone Bellavia, Marco Luigetti, Valerio Brunetti, Aldobrando Broccolini, Maurizio Gabrielli, Lorenzo Zileri Dal Verme, Paolo Calabresi, Giacomo Della Marca, Giovanni Frisullo

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05638620 (Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05638620 phase1completednot on this mapstarted 2023, after this paper: background citation

Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)

TypeinterventionalSponsorJonathann Kuo, MDRan2023 to 2023Enrolled20ConditionsPost Acute COVID-19 Syndrome, Long COVID, Long Covid19, COVID-19 RecurrentArmsstellate ganglion block with 0.5% bupivacaine
3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Autonomic dysfunction and quality of life in a cohort of neurology outpatients with post-acute sequelae of COVID-19, a two-year follow-up study.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2026
    Article
  2. Article
  3. Attenuated cardiac autonomic function in patients with long-COVID with impaired orthostatic hemodynamics.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Autonomic and neuropathic complaints of long-COVID objectified: an investigation from electrophysiological perspective.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Irene Scala *Catholic University of Sacred Heart, Rome, Italy.
Simone Bellavia *Catholic University of Sacred Heart, Rome, Italy.
Marco LuigettiDipartimento Di Scienze Dell'Invecchiamento, Ortopediche e della Testa-Collo, Fondazione Policlinico Universitario A. Gemelli IRCCS, Neurologiche, Rome, Italy. marco.luigetti@policlinicogemelli.it.ORCID http://orcid.org/0000-0001-7539-505X
Valerio BrunettiDipartimento Di Scienze Dell'Invecchiamento, Ortopediche e della Testa-Collo, Fondazione Policlinico Universitario A. Gemelli IRCCS, Neurologiche, Rome, Italy.
Aldobrando BroccoliniCatholic University of Sacred Heart, Rome, Italy.
Maurizio GabrielliDepartment of Emergency, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Largo Gemelli 8, 00168, Rome, Italy.
Lorenzo Zileri Dal VermeDigestive Disease Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Paolo CalabresiCatholic University of Sacred Heart, Rome, Italy.
Giacomo Della MarcaCatholic University of Sacred Heart, Rome, Italy.
Giovanni FrisulloDipartimento Di Scienze Dell'Invecchiamento, Ortopediche e della Testa-Collo, Fondazione Policlinico Universitario A. Gemelli IRCCS, Neurologiche, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEvidence is emerging about an extra-pulmonary involvement of SARS-CoV-2, including the nervous system. Autonomic dysfunction in patients recovering from acute coronavirus disease 2019 (COVID-19) has been recently described. Dysautonomic symptoms have been reported in the acute phase of the disease, but clear evidence is lacking, especially in the non-critical forms of the infection.

objectiveThe aim of this study is to assess the prevalence of dysautonomia in acute, non-critically ill COVID-19 patients.

methodsIn this observational, cross-sectional study, we compared 38 non-critically ill patients with acute COVID-19 (COVID + group) to 38 healthy volunteers (COVID - group) in order to assess the prevalence of signs and symptoms of dysautonomia through the administration of the composite autonomic symptom score 31 (COMPASS-31) and an active standing test. Comparisons between groups were performed by means of both univariate and multivariate analyses.

resultsThe prevalence of orthostatic hypotension was significantly higher in the COVID + group. Higher total scores of COMPASS-31 were observed in the COVID + group than controls. Significant differences between groups emerged in the secretomotor, orthostatic intolerance, and gastrointestinal COMPASS-31 domains. All these results maintained the statistical significance after the adjustment for concomitant drugs with a known effect on the autonomic nervous system assumed by the study participants, except for the differences in the gastrointestinal domain of COMPASS-31.

conclusionOur results suggest that an autonomic dysfunction could be an early manifestation of COVID-19, even in the contest of mild forms of the infection.

Indexed as

Autonomic Nervous System DiseasesCOVID-19Orthostatic IntoleranceCross-Sectional StudiesHumansSARS-CoV-2Autonomic dysfunctionCOMPASS-31COVID-19DysautonomiaOrthostatic hypotensionSARS-CoV-2

Identifiers

PMID35608736
PMCPMC9127042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.